Detected ·
Spruce Biosciences
$5.5M—
Spruce Biosciences has secured a combined $5.5M strategic investment from Cure Sanfilippo Foundation and the National MPS Society to fund an Expanded Access Program for TA-ERT, an investigational enzyme replacement therapy for Sanfilippo Syndrome Type B (MPS IIIB).
- Website
- —
- —
- Amount
- $5 500 000 USD
- Stage
- —
- Event
- Funding round
- Detected
- 2026-08-14 04:07:21 UTC
- Signal ID
- 3d27f1b3-390e-4c7f-8f1d-1bb791df563d
As the API returns it
{
"id": "3d27f1b3-390e-4c7f-8f1d-1bb791df563d",
"created_at": "2026-08-14T04:07:21.529560Z",
"company_name": "Spruce Biosciences",
"company_website_url": null,
"company_linkedin_url": null,
"event_type": "funding",
"funding_amount": 5500000,
"funding_currency": "USD",
"funding_stage": null,
"message": "*Spruce Biosciences has secured a combined $5.5M strategic investment from Cure Sanfilippo Foundation and the National MPS Society to fund an Expanded Access Program for TA-ERT, an investigational enzyme replacement therapy for Sanfilippo Syndrome Type B (MPS IIIB).*"
}